Three-year study examines trans women’s breast development from feminizing HRT
For trans women and transfeminine people who are considering or at the very beginning of feminizing hormone therapy, one of…
Special considerations for breast augmentation in trans women
Note: This post contains illustrations of breast anatomy. Among trans women and transfeminine people, breast augmentation surgery is both frequently…
No, not all trans people “always knew” since childhood
Previously: Timing of identity development and disclosure in LGBT youth (September 2018) New study on trans women’s developmental milestones: Self-awareness…
Trans men and transmasculine people on testosterone can grow prostate tissue
The general public’s knowledge of the nature of the physical changes induced by medical transition can be surprisingly spotty: trans…
Open questions: Trans men and transmasculine people can experience abdominal and pelvic pain after starting testosterone
Collaboration between the transgender community and health researchers plays an essential role in ensuring that our population’s knowledge and interests…
New study: Supprelin LA and less-expensive Vantas implant equally effective for blocking puberty in trans youth
Previously, I’ve noted some rather concerning confusion among anti-trans activists on the subject of implanted puberty-blocking medications used in trans…
Update on cases of lymphoma linked to textured breast implants in transgender women (BIA-ALCL)
I’ve previously covered emerging findings on breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), a type of non-Hodgkin’s lymphoma caused by the…
Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk of adverse effects
Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Update on case reports: Cyproterone acetate and meningioma in…
Once-yearly implanted puberty blockers may last for two years or more
Disclaimer: I am not a medical professional and this is not medical advice. GnRH agonists are a class of medications…
Trans women and transfeminine people taking HRT are far less likely to develop prostate cancer
Concerns over supposedly cancer-causing effects of cross-sex hormone therapy are an area in which public alarm has often pulled far…